Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-19

Clinical Trial Update: Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN [NA]

View source ↗

Summary

Feasibility study of a new diagnostic/predictive method for painful chemotherapy-induced peripheral neuropathy (CIPN) terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Burning Pain, Impaired Balance | NA | Status: TERMINATED | Results posted: 2018-12-19